Citadel Advisors
CDLX icon

Citadel Advisors’s Cardlytics CDLX Stock Holding History

Citadel Advisors’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.4K Sell
17,020
-6,260
-27% -$46.8K ﹤0.01% 12867
2026
Q1 		$244K Sell
23,280
-2,680
-10% -$26.1K ﹤0.01% 10965
2025
Q4 		$299K Sell
25,960
-10,740
-29% -$166K ﹤0.01% 10166
2025
Q3 		$892K Buy
36,700
+24,200
+194% +$403K ﹤0.01% 7779
2025
Q2 		$206K Sell
12,500
-6,160
-33% -$106K ﹤0.01% 10628
2025
Q1 		$340K Sell
18,660
-15,390
-45% -$440K ﹤0.01% 9303
2024
Q4 		$1.26M Sell
34,050
-13,830
-29% -$529K ﹤0.01% 6551
2024
Q3 		$1.53M Buy
47,880
+19,800
+71% +$1.1M ﹤0.01% 6009
2024
Q2 		$2.31M Sell
28,080
-11,560
-29% -$1.25M ﹤0.01% 5050
2024
Q1 		$5.74M Buy
39,640
+8,800
+29% +$743K ﹤0.01% 3732
2023
Q4 		$2.84M Sell
30,840
-10,640
-26% -$1.08M ﹤0.01% 4739
2023
Q3 		$6.84M Buy
41,480
+34,520
+496% +$4.48M ﹤0.01% 3191
2023
Q2 		$440K Buy
6,960
+1,680
+32% +$102K ﹤0.01% 8218
2023
Q1 		$179K Sell
5,280
-2,830
-35% -$148K ﹤0.01% 10369
2022
Q4 		$469K Buy
8,110
+1,380
+21% +$85.2K ﹤0.01% 8377
2022
Q3 		$633K Buy
6,730
+2,660
+65% +$379K ﹤0.01% 7944
2022
Q2 		$908K Sell
4,070
-150
-4% -$50.2K ﹤0.01% 7230
2022
Q1 		$2.32M Sell
4,220
-3,540
-46% -$2.14M ﹤0.01% 5765
2021
Q4 		$5.13M Buy
7,760
+5,270
+212% +$4.03M ﹤0.01% 4241
2021
Q3 		$2.09M Sell
2,490
-1,480
-37% -$1.5M ﹤0.01% 6245
2021
Q2 		$5.04M Buy
3,970
+290
+8% +$327K ﹤0.01% 4413
2021
Q1 		$4.04M Sell
3,680
-2,280
-38% -$3.01M ﹤0.01% 4740
2020
Q4 		$8.51M Buy
5,960
+900
+18% +$960K ﹤0.01% 2855
2020
Q3 		$3.57M Sell
5,060
-870
-15% -$633K ﹤0.01% 3675
2020
Q2 		$4.15M Buy
5,930
+1,880
+46% +$1.09M ﹤0.01% 3348
2020
Q1 		$1.42M Buy
4,050
+2,790
+221% +$1.98M ﹤0.01% 4725
2019
Q4 		$792K Buy
+1,260
New +$616K ﹤0.01% 6012

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Citadel Advisors's CDLX Position: Q2 2026 in Review

Citadel Advisors opened a new position in Cardlytics (CDLX) in Q2 2026: 28,597 shares worth $128K. The stake represents ﹤0.01% of the portfolio and ranks #12479 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in CDLX as recently as Q4 2025.

Citadel Advisors first reported a position in CDLX in Q1 2018 and has held it in 29 quarters since. The position peaked at $29M in Q1 2021. 42 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.

  • Citadel Advisors held 28,597 shares of Cardlytics worth $128K as of Q2 2026.
  • Cardlytics was a new Citadel Advisors position in Q2 2026.
  • Cardlytics made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12479 holding.
  • Citadel Advisors first reported a position in Cardlytics in Q1 2018 and has held it in 29 quarters since.
  • Citadel Advisors's Cardlytics position peaked at $29M in Q1 2021.
  • 42 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.